Zobrazeno 1 - 10
of 63
pro vyhledávání: '"A V, Kokhno"'
Autor:
B. D. Chaltsev, A. V. Torgashina, A. M. Lila, T. V. Markova, S. I. Kutsev, O. P. Ryzhkova, A. A. Orlova, A. V. Kokhno, T. I. Solovyova, V. N. Dvirnyk, A. M. Kovrigina, T. N. Obukhova, E. N. Parovichnikova, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 92-101 (2023)
This article presents the first case of VEXAS syndrome identified in the Russian Federation as well as characteristics of currently known clinical manifestations and treatment approaches. The clinical observation described is an impressive example of
Externí odkaz:
https://doaj.org/article/384c3eebf67e4465a4859c058c2a6f75
Autor:
S. A. Vasiliev, L. A. Gorgidze, E. E. Efremov, G. Yu. Belinin, T. N. Moiseeva, L. S. Al-Radi, M. A. Sokolova, G. T. Guria, N. I. Zozulya, A. V. Kokhno
Publikováno v:
Атеротромбоз, Vol 12, Iss 1, Pp 138-158 (2022)
Plasma fibronectin is a high molecular weight adhesive glycoprotein. There are two types of fibronectin: plasma (soluble) and cellular derived (insoluble). Electron microscopy revealed two types of structural organization of fibronectin: compact and
Externí odkaz:
https://doaj.org/article/1ec369a36e0f44a49c62b4461251aeec
Autor:
Elena N. Parovichnikova, Irina A. Lukianova, Vera V. Troitskaya, Mikhail Yu. Drokov, Larisa A. Kuzmina, Andrei N. Sokolov, Alina V. Kokhno, Zalina T. Fidarova, Irina V. Galtseva, Yuliya O. Davydova, Anastasiia I. Kashlakova, Elena O. Gribanova, Eugene E. Zvonkov, Elena P. Sysoeva, Valentina N. Dvirnyk, Tatiana N. Obukhova, Andrei B. Sudarikov, Yuliya V. Sidorova, Sergei M. Kulikov, Yuliia A. Chabaeva, Valerii G. Savchenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 753-762 (2021)
Aim. To analyze the results of treatment in patients with acute myeloid leukemia (AML) within protocols AML-17 and modified AML-17 (mOML-17) as part of two consecutive pilot studies in order to develop the best treatment strategy for AML patients age
Externí odkaz:
https://doaj.org/article/ead7e57f92e747e7b74baee842d7e924
Autor:
M. A. Kislitsyna, T. N. Obukhova, A. V. Kokhno, L. A. Grebenyuk, A. V. Luchkin, L. A. Kuzmina, V. N. Dvirnyk, A. M. Kovrigina, I. V. Galtseva, B. V. Biderman, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 14, Iss 3, Pp 69-76 (2019)
In chronic lymphocytic leukemia, the risk of second tumors including hematological malignancies, with which the use of purine nucleosides and alkylating agents in treatment of chronic lymphocytic leukemia is most often associated, is significantly in
Externí odkaz:
https://doaj.org/article/2c0272a5f1b14294822c10d7f61d9113
Autor:
O. Yu. Davydova, I. V. Galtseva, E. N. Parovichnikova, A. V. Kokhno, N. M. Kapranov, V. V. Troitskaya, E. A. Mikhailova, Z. T. Fidarova, T. N. Moiseeva, L. A. Kuzmina, E. A. Lukina, T. N. Obukhova, L. A. Grebenyuk, A. M. Kovrigina, V. N. Dvirnyk, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 13, Iss 4, Pp 75-88 (2019)
Background . Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal diseases of the hematopoiesis system characterized by dismyelopoiesis and cytopenia, the presence of cytogenetic aberrations and a high risk of transformation into acute
Externí odkaz:
https://doaj.org/article/592c04ba19584ab391e530dd088ab289
Autor:
A. N. Petrova, E. Yu. Chelysheva, I. S. Nemchenko, A. V. Bykova, M. A. Gurianova, E. A. Kuzmina, N. N. Tsyba, A. V. Kokhno, A. G. Turkina
Publikováno v:
Russian journal of hematology and transfusiology. 68:21-34
Introduction. The option of observation without therapy with tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) patients is already included in Russian and international clinical guidelines. Evaluation of long-term follow-up results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23df6ea45c0b05bd6cc2203658b8ba47
https://doi.org/10.35754/0234-5730-2023-68-1-21-34
https://doi.org/10.35754/0234-5730-2023-68-1-21-34
Autor:
E N PAROVICHNIKOVA, I A LOUKIANOVA, V V TROITSKAYA, M Y DROKOV, T I LOBAOVA, L A KUZMINA, A N SOKOLOV, A V KOKHNO, Z T FIDAROVA, G A BASKHAEVA, O A GAVRILINA, V A VASILYEVA, T N OBUKHOVA, S A KUZNETSOVA, A B SUDARIKOV, V N DVIRNIK, I V GALTSEVA, J O DAVIDIVA, S M KULIKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Externí odkaz:
https://doaj.org/article/86c14a4b80d349a59c1c8acc0003408d
Publikováno v:
Онкогематология, Vol 13, Iss 1, Pp 63-72 (2018)
Myelodysplastic syndromes (MDS) are heterogeneous group of clonal hematological neoplasms characterized by cytopenias, sighs of dysplasia and high risk of transformation in acute myeloid leukemia. Diagnostics of MDS requires a comprehensive approach,
Externí odkaz:
https://doaj.org/article/d5b0ebb7af984b04854e8f50ce3b65cf
Autor:
V V Troitskaya, E N Parovichnikova, A N Sokolov, A V Kokhno, L A Kuzmina, D S Badmazhapova, Z T Fidarova, O A Gavrilina, A A Sidorova, G M Galstyan, S A Keselman, T V Gaponova, V S Galuzyak, S K Kravchenko, E O Gribanova, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 33-40 (2015)
Aim. To evaluate the efficiency of the treatment policy for patients with acute myeloid leukemia (AML) and hyperleukocytosis (HL), which is aimed at preventing rapid hypercytolysis and massive tumor lysis (cytolysis) syndrome and/or at reducing the d
Externí odkaz:
https://doaj.org/article/8267e2799105405f9dace82189c90369
Publikováno v:
Терапевтический архив, Vol 86, Iss 7, Pp 97-103 (2014)
To interpret hematopoietic cell myelodysplastic changes found during the primary diagnosis of myelodysplastic syndromes or other diseases and during therapy is an enormously complex clinical and laboratory problem. In what cases do these changes serv
Externí odkaz:
https://doaj.org/article/43f94a9f0146449189983c2249e270a4